Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ATP-sensitive potassium channels.

G C Rodrigo1, N B Standen

  • 1Department of Cell Physiology and Pharmacology, University of Leicester, PO Box 138, Leicester LE1 9HN, UK.

Current Pharmaceutical Design
|June 25, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time-of-day variation in vascular function.

Experimental physiology·2016
Same author

Remote ischaemic conditioning and remodelling following myocardial infarction: current evidence and future perspectives.

Heart failure reviews·2016
Same author

Insulin-like growth factor-I inhibits rat arterial K(ATP) channels through pI 3-kinase.

Biochemical and biophysical research communications·2008
Same author

Modulation of hERG potassium currents in HEK-293 cells by protein kinase C. Evidence for direct phosphorylation of pore forming subunits.

The Journal of physiology·2007
Same author

Glucose reduces endothelin inhibition of voltage-gated potassium channels in rat arterial smooth muscle cells.

The Journal of physiology·2006
Same author

Can optical recordings of membrane potential be used to screen for drug-induced action potential prolongation in single cardiac myocytes?

Journal of pharmacological and toxicological methods·2006
Same journal

Role of Phenolic Nanocompounds in Inflammatory Disorders: Current View and Future Aspects.

Current pharmaceutical design·2026
Same journal

Overcoming Physiological Barriers in Brain Tumor Therapy: Advances in Nanomedicine, Ultramolecular Pharmaceuticals, and Targeted Drug Delivery.

Current pharmaceutical design·2026
Same journal

Breathing Life into Research: The Transformative Potential of Lung-on-a-Chip Technology.

Current pharmaceutical design·2026
Same journal

Cross-Tissue Transcriptome-Wide Association Study Prioritizes Candidate Genes and Compound-Associated Signatures for Osteoarthritis.

Current pharmaceutical design·2026
Same journal

Emerging Role of AI in Gastroenterology and Hepatology: Revolutionizing Medical Device-Assisted Diagnosis.

Current pharmaceutical design·2026
Same journal

Nanostructured Lipid Carriers in Drug Targeting: Characterization, Patents, and Recent Innovations.

Current pharmaceutical design·2026
See all related articles

ATP-sensitive potassium (K(ATP)) channels are crucial for linking cell excitability to metabolism. This review highlights their diverse roles in non-pancreatic tissues, including muscle and brain, and their therapeutic potential.

Area of Science:

  • Physiology
  • Molecular Biology
  • Pharmacology

Background:

  • ATP-sensitive potassium (K(ATP)) channels are integral membrane proteins composed of Kir6 and sulfonylurea receptor subunits.
  • Their expression varies across tissues, including the heart, smooth muscle, skeletal muscle, and brain.
  • K(ATP) channels are regulated by intracellular nucleotides, phospholipids, and protein kinases/phosphatases.

Purpose of the Study:

  • To review the function and regulation of non-pancreatic ATP-sensitive potassium (K(ATP)) channels.
  • To explore their roles in various physiological processes and disease states.
  • To discuss current and potential therapeutic applications of K(ATP)) channel modulators.

Main Methods:

  • Literature review of existing research on K(ATP) channels.

Related Experiment Videos

  • Analysis of studies focusing on non-pancreatic tissue expression and function.
  • Synthesis of information on pharmacological targeting and therapeutic implications.

    • Main Results:

    • Non-pancreatic K(ATP) channels regulate vascular smooth muscle tone, leading to vasodilation.
    • Cardiac K(ATP) channels are involved in cellular protection during stress and ischemic preconditioning.
    • Skeletal muscle and neuronal K(ATP) channels play roles in fatigue, glucose uptake, and neuroprotection.

    Conclusions:

    • K(ATP) channels are critical regulators of cellular function and excitability in diverse non-pancreatic tissues.
    • Modulation of K(ATP) channels offers therapeutic potential for cardiovascular, metabolic, and neurological conditions.
    • Further research into mitochondrial K(ATP) channels and tissue-specific drug development is warranted.